|
|
|
|
Peritoneal Dialysis International
Journal of Medical Microbiology
Biomaterials http://www.elsevier.nl/inca/publications/store/3/0/3/9/2/
Journal of Applied Biomaterials and Biomechanics http://www.jabb.biz/index.asp?a=current
Biofouling http://www.tandf.co.uk/journals/titles/08927014.html
Medical Device Daily http://www.ahcpub.com/ahc_root_html/products/newsletters/mdw.html
Literature and Links relating to Biofilm (on catheters)
Some interesting literature about biofilm and catheters:
A lot of info about formation of biofilms (also on
catheters), including pictures, can be found on:
Battling biofilm: an overview by Kelly M. Pyrek:
Research report about an anti-infective coating for
polymer surfaces:
Research report about biofilms:
Study report: "Biofilms, the new microbial order", from
the Universtity Hospitals of Cleveland and the Case Western Reserve
University.
Study report:
Hydrodynamic influences on
biofilm formation and growth in:
Article about a biofilm primer:
Activities of the biofilm research group of the
University of Calgary:
Article about quantification of biofilm:
A new book about biofilms: Medical Implications
of Biofilms, Edited by Michael Wilson, Deirdre Devine, £65.00,
September 2003, 328 pages, ISBN: 0521812402. This book is available at:
http://books.cambridge.org/0521812402.htm
Biofilm and Peritoneal Dialysis Literature Survey
- Danese P., Microbia, Inc., One Kendall Square, Building 1400W, 02139, Cambridge, MA, USA: Antibiofilm approaches. Prevention of catheter colonization, Chem Biol 2002 Aug; 9(8): 873 - Dasgupta M.K., Larabie M., Department of Medicine, University of Alberta, Edmonton, Canada: Biofilms in peritoneal dialysis, Perit Dial Int 2001; 21 Suppl 3: S213-7 - Dasgupta M.K., Department of Medicine, University of Alberta, School of Medicine, Edmonton, Canada: Biofilms causes decreased production of interferongamma, J Am Soc Nephrol 1996 June; 7(6): 877-82 - Dasgupta M.K., Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada: Biofilms and infection in dialysis patients, Semin Dial 2002 Sep-Oct; 15(5): 338-46 - Dasgupta M.K., Kowalewaska-Grochowska K, Costeron J.W., University of Alberta, Edmonton, Canada: Biofilms and peritonitis in peritoneal dialysis, Perit Dial Int 1993; 13 Suppl 2: S322-5 - Dasgupta M.K., Costeron J.W., Department of Medicine, University of Alberta, Edmonton, Canada: Significance of biofilm-adherent bacterial microcolonies on Tenckhoff catheters of CAPD patients, Blood Purif 1989; 7(2-3): 144-55 - Dasgupta M.K., Ward K., Noble P.A., Larabie M., Costeron J.W., Department of Medicine, 2E3.22 Walter Mackenzie Centre, University of Alberta, Edmonton, Canada: Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid, Am J Kidney Dis 1994 May; 23(5): 709-16 - Gorman S.P., Adair C.G., Mawhinney W.M., School of Pharmacy, Queen’s University of Belfast, UK: Incidence and nature of peritoneal catheter biofilm determined by electron and confocal laser scanning microscopy, Epideriol Infect 1994 June; 112(3): 551-9 - Finkelstein E.S., Jekel J., Troidle L., Gorban-Brennan N., Finkelstein F.O., Bia F.J., Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA: Patterns of infection in patients maintained on longterm peritoneal dialysis therapy with multiple episodes of peritonitis, Am J Kidney Dis 2002 June; 39(6): 1278-86 - Holmes C.J., Baxter Healthcare Corporation, Round Lake, Illinois, USA: Catheter-associated biofilm, Contrib Nephrol 1990; 85: 49-56 - Khaled G.H., Finkelstein F.O., Carey H.B., Wardlaw S.C., Kliger A.S., Edberg S.C., Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA: Method for studying development of colonization and infection of dialysis catheters, Adv Perit Dial 2001; 17: 163-71 - Khardoni N., Yassien M., Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield 62794-9230, USA: Biofilms in device-related infections, J Ind Microbiol 1995 Sep; 15(3): 141-7 - Kim Y.L., Cho S., Kim J.C., Cho D.K., Kim Y.J., Larm O., Mathiesen T., Lindholm B., Bergstrom J., Department of Internal Medicine, School of Medicine, Kyungpook National University, Taegu, South Korea: Effect in a rat model of heparinized peritoneal dialysis catheters on bacterial colonization and the healing of exit site, Perit Dial Int 2001; 21 Suppl 3: S357-8 - Pascual A., Department of Microbiology, School of Medicine, Sevilla, Spain: Pathogenesis of catheter-related infections: lessons for new designs, Clin Microbiol Infect 2002 May; 8(5): 256-64 - Richards G.K., Gagnon R.F., Obst G., Kostiner G.B., South Saskatchewan Hospital Centre, Regina, Canada: The effect of peritoneal dialysis solutions on rifampin action against Staphylococcus epidermis in the fluid and biofilm phases of growth, Perit Dial Int 1993; 13 Suppl 2: S341-4
Some literature corresponding to the field of peritoneal peritonitis (selection, 12/01/04)
Hermsen ED, Hovde LB, Hotchkiss JR, Rotschafer JC. Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model. Antimicrob Agents Chemother. 2003 Dec;47(12):3764-7. Kan GW, Thomas MA, Heath CH. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients? Perit Dial Int. 2003 Sep-Oct;23(5):465-8. Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int. 2003 Sep-Oct;23(5):456-9. Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos DG. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment. Int J Artif Organs. 2003 Aug;26(8):698-714. Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D'Amato G, Balaban N, Saba V, Scalise G. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation. 2003 Aug 12;108(6):767-71. Epub 2003 Jul 28. Giacometti A, Cirioni O, Gov Y, Ghiselli R, Del Prete MS, Mocchegiani F, Saba V, Orlando F, Scalise G, Balaban N, Dell'Acqua G. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Jun;47(6):1979-83. Finelli A, Gallant CV, Jarvi K, Burrows LL. An “In-Biofilm Expression Technology (IBET) approach to identification of genes involved in Pseudomonas aeruginosa biofilm development. J.Bacteriol. 185: 2700-2710, 2003 Araki Y, Hataya H, Ikeda M, Ishikura K, Honda M. Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis. Perit Dial Int. 2003 May-Jun;23(3):267-9. Chiang P, Burrows LL. Biofilm formation by hyperpiliated mutants of Pseudomonas aeruginosa. J. Bacteriol. Apr;185(7): 2374-8, 2003 Chung JH, Park MH, Kim JH, Lim Y, Shin SH. Growth and siderophore production of staphylococci in human peritoneal dialysate. J Korean Med Sci. 2003 Apr;18(2):158-62. Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, Viticchi C, Del Prete MS, Saba V, Scalise G, Dell'Acqua G. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis. 2003 Feb 15;187(4):625-30. Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial. 2003 Jan-Feb;16(1):30-7. Review. De Mattos EM, Teixeira LA, Alves VM, Rezenda e Resende CA, da Silva Coimbra MV, da Silva-Carvalho MC, Ferreira-Carvalho BT, Figueiredo AM. Isolation of methicillin-resistant coagulase-negative staphylococci from patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and comparison of different molecular techniques for discriminating isolates of Staphylococcus epidermidis. Diagn Microbiol Infect Dis. 2003 Jan;45(1):13-22. Balaban N, Gov Y, Bitler A, Boelaert JR Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int. 2003 January, 63 (1):340-5. Ariano RE, Franczuk C, Fine A, Harding GK, Zelenitsky SA. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients. Perit Dial Int. 2002 May-Jun;22(3):335-8. Zelenitsky S, Franczuk C, Fine A, Ariano R, Harding G. Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids. J Antimicrob Chemother. 2002 May;49(5):863-6. Gardam MA, Burrows LL, et al. Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J.Infect Dis. 186(12):1754-60,2002 Pepperell C, Kus JV, Gardam MA, Humar A, Burrows LL. Low-virulence Citrobacter species encode resistance to multiple antimicrobials. Antomicrob Agents Chemother;46(11):3555-60, 2002 Finelli A, Burrows LL, Oreopolous D, et al. Colonization-resistant antimicrobialcoated peritoneal dialysis catheters: Evaluation in a newly developed rat model of persistent Pseudomonas aeruginosa peritontitis. Perit. Dial. Int. 22: 27-31, 2002 Forward KR, Willey BM, Burrows LL, et al. Molecular mechanism of cephamycin resistance in Escherichia coli from Toronto Invasive Bacterial Diseases Network (TIBDN) hospitals. Diagn. Microbiol. Infect. Dis 41: 57-63, 2001
|
This Web Site was developed by R.I.L.A.B. s.r.l., Genova, Italy (www.rilab.it). For
questions or comments regarding this Web Site please contact [info@rilab.it] .
|
